Orasure Technologies (OSUR) Cash from Financing Activities (2010 - 2025)
Orasure Technologies (OSUR) posted Cash from Financing Activities of -$5.1 million for Q3 2025, up 12.4% sequentially from -$5.8 million in Q2 2025, and down 599.59% YoY from $1.0 million in Q3 2024.
Orasure Technologies (OSUR) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Orasure Technologies has reported Cash from Financing Activities for 16 years, with the latest figure at -$5.1 million in Q3 2025.
- Quarterly Cash from Financing Activities fell 599.59% year-over-year to -$5.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$11.9 million (down 170.16% YoY) and the FY2024 annual result came in at -$4.2 million, down 38.14% from the prior year.
- Cash from Financing Activities improved to -$5.1 million in Q3 2025 per OSUR's latest filing, from -$5.8 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $235000.0 in Q4 2021 and troughed at -$5.8 million in Q2 2025.
- A 5-year average of -$1.4 million and a median of -$801000.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 68.73% in 2024, then plunged 599.59% in 2025.
- Over 5 years, Cash from Financing Activities stood at $235000.0 in 2021, then slumped by 440.85% to -$801000.0 in 2022, then surged by 55.68% to -$355000.0 in 2023, then surged by 68.73% to -$111000.0 in 2024, then tumbled by 4475.68% to -$5.1 million in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$5.1 million, -$5.8 million, and -$953000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Orasure Technologies | 282.89 Mn | 83.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -5.08 Mn |
| Sep 30, 2025 | -5.08 Mn |
| Jun 30, 2025 | -5.80 Mn |
| Jun 30, 2025 | -5.80 Mn |
| Mar 31, 2025 | -953,000.00 |
| Mar 31, 2025 | -953,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Sep 30, 2024 | -726,000.00 |
| Sep 30, 2024 | -726,000.00 |
| Jun 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Dec 31, 2023 | -355,000.00 |
| Dec 31, 2023 | -355,000.00 |
| Sep 30, 2023 | -705,000.00 |
| Sep 30, 2023 | -705,000.00 |
| Jun 30, 2023 | -632,000.00 |
| Jun 30, 2023 | -632,000.00 |